Samodzielny Publiczny Dzieciecy Szpital Kliniczny Im. Jozefa Polikarpa Brudzinskiego W Warszawie
- Address
- lock Available on a paid plan
Pediatric Oncology and Hematology
At Samodzielny Publiczny Dzieciecy Szpital Kliniczny Im. Jozefa Polikarpa Brudzinskiego W Warszawie, clinical research in neoplasms and hematologic diseases focuses mainly on acute lymphoblastic leukemia and immune-related blood disorders. These studies are designed to improve treatment effectiveness, reduce treatment-related toxicity, and support better disease control in children.
- Children with acute lymphoblastic leukemia
- Hemic and lymphatic diseases and neoplasms
- Testing new treatment approaches and improving safety
Research in this area includes efforts to strengthen leukemia care while also exploring better options for chronic idiopathic thrombocytopenic purpura and congenital thrombotic thrombocytopenic purpura.
Neurology and Rare Epilepsies
The site has an active program in nervous system diseases, with a strong focus on developmental and epileptic encephalopathies. These trials aim to assess long-term safety and tolerability of new therapies while supporting symptom control in children with difficult-to-treat epilepsy syndromes.
- Dravet syndrome
- Lennox-Gastaut syndrome
- CDKL5 deficiency disorder and related rare epilepsies
This research helps evaluate whether newer treatment options can offer safer, more durable seizure management for pediatric patients.
Respiratory and Interstitial Lung Disease
Clinical trials in respiratory tract diseases are centered on childhood interstitial lung disease and other fibrosing lung conditions. The main purpose is to monitor safety and tolerability of treatments intended to slow disease progression and support long-term lung health.
- Childhood interstitial lung disease
- Fibrosing interstitial lung disease
- Evaluating long-term treatment safety
These studies are especially important in pediatric care, where preserving lung function can have a major impact on growth and daily life.
Digestive and Inflammatory Bowel Disease Research
Work in digestive system diseases includes studies in Crohn's disease, with attention to inflammation in the upper gastrointestinal tract. The research is aimed at improving symptom control and finding more effective local treatment options for children.
- Crohn's disease
- Inflammatory lesions of the esophagus, stomach, and duodenum
- Testing treatment effectiveness for intestinal inflammation
These trials add to the pediatric gastroenterology expertise available at the site and help refine care for complex inflammatory bowel disease.
Immune and Autoimmune Disorders
Several studies address immune system diseases, especially conditions where the body’s immune response must be carefully regulated. The research explores new therapies for chronic immune thrombocytopenia, congenital thrombotic thrombocytopenic purpura, and other immune-mediated disorders.
- Chronic idiopathic thrombocytopenic purpura
- Congenital thrombotic thrombocytopenic purpura
- Improving immune control and treatment safety
At this Warsaw pediatric center, these trials focus on whether newer immune-targeted therapies can better support children with serious blood-related autoimmune conditions.
Metabolic and Endocrine Conditions
Research in nutritional and metabolic diseases includes studies for children at risk of type 1 diabetes and those with hyperkalaemia. The goal is to improve early intervention, restore normal metabolic balance, and support safer long-term disease management.
- Presymptomatic diabetes type 1
- Hyperkalaemia
- Testing approaches to prevent progression and stabilize metabolism
These trials reflect a broader interest in early detection and practical treatment strategies for pediatric metabolic disorders.
Pediatric Neuroimmunology and Demyelinating Disease
The site also conducts research in nervous system and immune-related conditions such as relapsing multiple sclerosis. These studies are designed to evaluate how well new therapies can control disease activity and maintain long-term safety in children and adolescents.
- Relapsing multiple sclerosis
- Neuroinflammatory disease
- Assessing effectiveness and ongoing safety of treatment
This line of research supports better management of chronic neurologic disease in a pediatric setting.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 of 7 therapeutic areas and 15 of 42 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 42 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 7 by active trials.
lock +6 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Samodzielny Publiczny Dzieciecy Szpital Kliniczny Im. Jozefa Polikarpa Brudzinskiego W Warszawie
lock Showing 1 of 11 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2, Prospective, Interventional, Open-Label, Multisite, Extension Study to Assess the Long-Term Safety and Tolerability of Soticlestat (TAK-935) as Adjunctive Therapy in Subjects with Developmental Epileptic Encephalopathies Including Dravet Syndrome, Lennox Gastaut Syndrome, CDKL5 Deficiency Disorder, and Chromosome 15 Duplication Syndrome (ENDYMION 1) | Takeda Development Center Americas Inc. | Phase II | Not Recruiting | Jul 2019 | Mar 2025 |
IMP list
lock Showing 1 of 42 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Cyclophosphamide | 2 | Unknown | 2021-07-01 | 2024-11-18 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.